HR 7064
AI in Health Care Efficiency and Study Act
TL;DR
Rep. Pablo Jose Hernández (D-PR) introduced this bill to study how AI is being used in healthcare and identify ways it can improve efficiency across the U.S. health system. It doesn't impose new rules on companies; it directs a federal study and report on AI applications in medical settings.
How This Might Impact Your Business
Healthcare providers, insurers, and health tech vendors would see a federal study on AI use cases, but no immediate compliance obligations
Companies selling AI diagnostic tools, clinical decision support software, or administrative automation to hospitals should expect their products to be examined in the resulting report
No penalties, audits, or reporting requirements are created for private businesses
Findings from the study could shape future regulation, reimbursement policy, or federal procurement preferences for AI in healthcare
Currently sits in the House Energy and Commerce Committee with no scheduled markup, meaning movement is uncertain
Small and mid-sized health tech vendors have a window to engage with policymakers before recommendations are finalized
No exemptions are relevant since the bill is study-based, not regulatory
What Should You Do
Ask your government affairs or policy team to track this bill through the House Energy and Commerce Committee and flag any hearings
If you sell AI tools to hospitals, payers, or clinics, prepare a one-pager on efficiency gains and outcomes data that could inform the federal study
Health tech vendors should consider submitting comments or meeting with committee staff to shape the study's scope
Review your internal AI use cases in healthcare operations (scheduling, coding, claims, diagnostics) so you can benchmark against likely federal findings
Watch for the study's release timeline, since results often preview future Medicare, Medicaid, or FDA policy shifts
Who It Affects
Sponsors
Status Timeline
committee
Referred to the House Committee on Energy and Commerce.
January 14, 2026